TABLE 3.
Chromosome aberrations
Genotype | No. of metaphases analyzed | No. of chromosomes per metaphase (mean ± SDsc) | No. of chromosome breaks | No. of chromatid breaks | No. of fragmentsa | No. of other aberrationsb | No. (%) of metaphases with aberrations |
---|---|---|---|---|---|---|---|
Mrad9+/+ | 106 | 41.40 ± 0.5 | 0 | 0 | 0 | 0 | 0 |
Mrad9Tar/− | 110 | 41.2 ± 1.0 | 1 (0.01/cell) | 1 (0.01/cell) | 0 | 1 (0.01/cell) | 3 (2.73) |
Mrad9−/− | 106 | 40.94 ± 1.0 | 6 (0.06/cell) | 3 (0.03/cell) | 8 (0.08/cell) | 8 (0.08/cell) | 14 (13.21) |
Mrad9−/−, pZeoSV2-Mrad9 | 106 | 40.6 ± 0.9 | 0 | 0 | 1 (0.01/cell) | 1 (0.01/cell) | 2 (1.89) |
Mrad9−/−, pZeoSV2-HRAD9 | 110 | 41.2 ± 0.7 | 2 (0.018/cell) | 1 (0.009/cell) | 1 (0.009/cell) | 1 (0.009/cell) | 2 (1.82) |
Centric and acentric fragments and interstitial deletions included.
Fusions included.
SD, standard deviation.